Status:
UNKNOWN
Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
Institut de Recherche pour le Developpement
Centre d'Infectiologie Charles Mérieux
Conditions:
Influenza -Like Illness
Covid19
Eligibility:
All Genders
6+ years
Brief Summary
The Respiratory infection COVID-19, due to a new coronavirus, SARS-CoV2, appeared in December 2019 in several people who attended the wildlife market in Wuhan, Hubei Province, China. While COVID-19 ha...
Detailed Description
1. INTRODUCTION This project is mainly based on two major questions that remain unsolved. The first one is the origin of the outbreak and the events that led to the transmission of SARS-CoV-2 to h...
Eligibility Criteria
Inclusion
- All permanent residents of the household who meet the inclusion criteria of \> 6 months old and living in their respective village for at least 6 months will be eligible to participate. All people from the anterior LACORIS study (2015-2019), will be invited to participate to the study.
- Over a year, active case finding for influenza-like illness (ILI) will be conducted among the cohort by staff at CILM. The suspected ILI cases will be first identified using the WHO clinical case definition of ILI and Covid 19 as either with:
- Acute onset of fever (\> 37.5˚C axillary temperature or \> 38˚C tympanic temperature) AND cough; OR Acute onset of ANY ONE OR MORE of the following signs or symptoms: Fever, cough, general weakness/fatigue, headache, myalgia, sore throat, coryza, dyspnoea, anosmia (loss of smell) or ageusia (loss of taste).
- with symptoms with onset within the last 10 days.
- Living in their respective village for 6 months or more.
- Physically reside in the village for more than 80% of the time during the duration of the study.
- Study subjects ≥ 6 months of age (no upper age limit).
- Consent form signed by patient, or if under 18 years of age or patients with learning difficulty or other vulnerability with impaired ability to decide on consent, signed by parent or guardian.
- Agrees to comply with study requirements.
Exclusion
- Study subjects under the age of 6 months.
- Study subjects or parents/guardians that do not accept participation.
- Study subjects or parents/guardians who refuse to sign informed consent.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
5400 Patients enrolled
Trial Details
Trial ID
NCT04716543
Start Date
August 1 2021
End Date
March 1 2022
Last Update
July 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.